Hey Doc,
As a scientist, I find your analysis to be a little simplistic and I am hoping, not intentionally misleading.
Just a couple of clarifications:
1) Remdesmivir = nucleotide analogue with a higher binging affinity to the catalytic site than the natural substrate (Notoriously challenging to produce, involving significant investment of time, money and effort. Unfortunately, commonly undermined by selection of drug resistant mutants. Mode of action: stops viral replication
2) hydroxychloroquine = antimalarial with no antiviral activity demonstrated in humans. At most, it has been demonstrated in a mouse model, and suspected mode of action is increasing endosome acidity, preventing release of virus into the cytoplasm. Again stops viral replication
3)MSCs demonstrable immuno-modulatory effect, preventing cytokine storming in ARDS. No impact on viral replication.
Speculating that there is an equivalence in likelihood of Phase 3 outcomes is being a little loose with the science....but I do thank you for your service to the community as a health care worker during this time
Cheers
V
- Forums
- ASX - By Stock
- MSB
- MESO action tonight
MESO action tonight, page-598
-
- There are more pages in this discussion • 2,562 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
-0.020(1.68%) |
Mkt cap ! $1.370B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.17 | $2.784M | 2.334M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 24546 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 20493 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 55764 | 1.165 |
16 | 140264 | 1.160 |
9 | 155194 | 1.155 |
9 | 428385 | 1.150 |
2 | 14925 | 1.145 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 34434 | 12 |
1.180 | 77004 | 13 |
1.185 | 72126 | 10 |
1.190 | 23205 | 7 |
1.195 | 26438 | 6 |
Last trade - 12.05pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |